Northwire Canada EditionThursday, October 15, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Production / Operations Routine +

MustGrow Receives Georgia Registration for TerraSante(TM) Biofertility Product

MustGrow Expands U.S. Footprint with Georgia Registration Amidst Revenue Scaling Challenges

By The Northwire Desk — AI Analysis Apr 28, 2026 · 07:01 MGRO · 0.57 MustGrow Biologics Corp.
Executive Summary
  • MustGrow Biologics Corp. received registration approval from the Georgia Department of Agriculture for its TerraSante(TM) organic biofertility product.
  • This expansion allows sales in Georgia, complementing existing registrations in California, Florida, Arizona, Idaho, Oregon, and Washington State.
  • The product is a mustard-derived wettable powder designed to improve soil microbiome health and crop yields.
  • Target markets include high-value crops such as peanuts ($762 million USD cash receipts), pecans ($184 million), and blueberries ($156 million).
  • Approval leverages existing Organic OMRI Listed® certifications and California's OIM Program status.
Material Impact
  • The news represents an incremental step in the company's commercialization roadmap rather than a sudden market-moving event.
  • Regulatory approvals for biofertilizers are typically sequential state-by-state processes; Georgia was anticipated following previous U.S. expansions mentioned in December 2025 communications.
  • While Georgia is a significant agricultural market, registration alone does not guarantee immediate revenue volume without confirmed sales contracts or distribution agreements.
  • The stock price has already reacted to prior financing and trial data (January 2026 spike to $0.90 followed by decline), suggesting this specific regulatory milestone may be partially priced in.
  • No new strategic investors, M&A activity, or major contract wins are disclosed that would elevate this to a "Game Changer" status.
MGRO · Price
Company Overview
  • MustGrow Biologics Corp. develops mustard-derived biofertilizers and biocontrol products for agriculture.
  • Flagship Product (TerraSante): Organic biofertility product registered in 7 U.S. states; designed to improve soil health and yield efficiency.
  • Secondary Product (TerraMG): Biocontrol product targeting clubroot disease in canola, currently undergoing field trials and Health Canada registration.
  • Distribution Arm: NexusBioAg serves as the Canadian sales and distribution channel for TerraMG.
  • Manufacturing: Scaling capacity via contract manufacturers in Asia to meet growing demand and improve margins.
Read the original news release →

More from MustGrow Biologics Corp.

Jun 19, 2026 · 17:01

MustGrow Biologics Raises $3.7M to Fund TerraSante Biofertility Ramp Amid Persistent Cash Burn

Financings Jun 17, 2026 · 19:22

MustGrow Biologics raises $3.7M to fund TerraSante ramp-up amid persistent cash burn.

Financings May 28, 2026 · 17:01

MustGrow Biologics Secures Liquidity Amidst Early Revenue Growth and Manufacturing Transition

Earnings May 25, 2026 · 18:01

MustGrow Biologics Secures Capital for U.S. Expansion Amidst Revenue Growth

Financings May 25, 2026 · 07:00

Regulatory Expansion Validates Growth Strategy But Cash Burn Remains Critical Risk

Regulatory May 14, 2026 · 17:15

MustGrow Biologics Corp.

Other